Clinical Trial Update: Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI) [NA]

View source ↗

Summary

A clinical trial investigating the effects of citicoline and omega-3 fatty acids in veterans with traumatic brain injury was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Dependence
• Substance Use Disorder
• Traumatic Brain Injury

Drugs mentioned

• Citicoline (CDP-choline)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Deborah Yurgelun-Todd | Conditions: Traumatic Brain Injury, Substance Abuse | NA | Status: WITHDRAWN